Gene test guides treatment for rare salivary gland tumors

This study tested whether analyzing the genes of a person's salivary gland tumor could help doctors pick a more effective drug. 114 people with advanced or returning cancer joined. First, their tumor was genetically profiled. Then, if a targetable gene change was found, they got a drug matched to that change; if not, they got a different drug called Selinexor. The goal was to see if matched therapy could shrink or control the tumor better. The study is complete, but results are not yet reported.